Breaking News, Collaborations & Alliances

BioNTech, Genmab Expand Global Strategic Oncology Collaboration

Will jointly work to research, develop and commercialize novel monospecific antibody candidates for various cancer indications.

Author Image

By: Charlie Sternberg

Associate Editor

BioNTech SE and Genmab A/S are expanding their global strategic collaboration to develop and commercialize novel immunotherapies for the treatment of cancer patients.   Under this expansion, BioNTech and Genmab will jointly work to research, develop and commercialize novel monospecific antibody candidates for various cancer indications.   Since 2015, the companies have been working on the joint development of bispecific cancer antibodies aimed at improving immunotherapy options for cancer pa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters